- Comparison of the oncological outcomes of stenting as a bridge to surgery and surgery alone in stages II to III obstructive colorectal cancer: a retrospective study
-
Uehara H, Yamazaki T, Iwaya A, Kameyama H, Komatsu M, Hirai M
- KMID: 2531262
- Ann Coloproctol.
- 2022 Jun;38(3):235-243.
- doi: 10.3393/ac.2020.01067.0152
Purpose: We evaluated the oncological outcomes of bridge to surgery (BTS) using stent compared with surgery alone for obstructive colorectal cancer. Methods: Consecutive patients who underwent curative resection for stages II... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Slow Nutrient Drinking Test for Evaluating Postprandial Distress Symptom in Japanese Patients With Functional Dyspepsia
-
Watanabe T, Masaoka T, Kameyama H, Kanai T
- KMID: 2531216
- J Neurogastroenterol Motil.
- 2022 Jul;28(3):424-430.
- doi: 10.5056/jnm21075
Background/Aims Functional dyspepsia (FD), one of the functional gastrointestinal disorders, is highly prevalent. Impaired gastric accommodation is proposed as a pathophysiology of FD. In order to assess gastric accommodation, a slow... -
- CITED
-
- Close
- SHARE
-
- Close
- Small Bowel Obstruction After Ileal Pouch-Anal Anastomosis With a Loop Ileostomy in Patients With Ulcerative Colitis
-
Kameyama H, Hashimoto , Shimada Y, Yamada S, Yagi R, Tajima Y, Okamura T, Nakano M, Miura K, Nagahashi , Sakata J, Kobayashi , Kosugi SI, Wakai T
- KMID: 2411568
- Ann Coloproctol.
- 2018 Apr;34(2):94-100.
- doi: 10.3393/ac.2017.06.14
PURPOSE: Small bowel obstruction (SBO) remains a common complication after pelvic or abdominal surgery. However, the risk factors for SBO in ulcerative colitis (UC) surgery are not well known. The... -
- CITED
-
- Close
- SHARE
-
- Close
- Pathophysiology of Potassium-competitive Acid Blocker–refractory Gastroesophageal Reflux and the Potential of Potassium-competitive Acid Blocker Test
-
Masaoka T, Kameyama H, Yamane T, Yamamoto Y, Takeuchi H, Suzuki H, Kitagawa Y, Kanai T
- KMID: 2422848
- J Neurogastroenterol Motil.
- 2018 Oct;24(4):577-583.
- doi: 10.5056/jnm18036
BACKGROUND/AIMS: Potassium-competitive acid blockers are expected to be the next generation of drugs for the treatment of diseases caused by gastric acid. In 2015, vonoprazan fumarate, a novel potassium-competitive acid... -
- CITED
-
- Close
- SHARE
-
- Close
